This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Astra. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Bo Ahr En: Innovator in Galanin Antagonist Research
Introduction
Bo Ahr En is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmacology, particularly through his research on galanin antagonists. His work focuses on developing new peptides that can be utilized in pharmaceutical preparations.
Latest Patents
Bo Ahr En holds a patent for a galanin antagonist, which is a galanin receptor ligand. The patent describes new peptides, including Galanin (1-12)-Pro-Substance P(5-11), Galanin (1-12)-Pro-Bradykinin(2-9), Galanin (1-12)-Pro-Pro-Pro-(Leu.sup.5 -Enkephalin (5-1), and Galanin (1-12)-Pro-Lys(.epsilon.-NH-)Pro-(Leu5-Enkephalin (5-1). These peptides and their functional analogues and derivatives are intended for use in treating disorders in mammals that depend on the physiological function of galanin at the galanin receptor. He has 1 patent to his name.
Career Highlights
Bo Ahr En is associated with Aktiebolaget Astra, a prominent company in the pharmaceutical industry. His work has contributed to advancements in understanding the role of galanin in various physiological processes.
Collaborations
Throughout his career, Bo Ahr En has collaborated with esteemed colleagues such as Ulo Langel and Tamas Bartfai. These collaborations have further enriched his research and innovation in the field.
Conclusion
Bo Ahr En's contributions to the development of galanin antagonists highlight his role as an important figure in pharmacological research. His innovative work continues to pave the way for new therapeutic approaches.